121 related articles for article (PubMed ID: 10665286)
21. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
Li X; Jiang Y; Ye C; Li C
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
[TBL] [Abstract][Full Text] [Related]
22. [Value of peripheral retinopexy in proliferative diabetic retinopathy with hemorrhage of the vitreous body. A 5-year study].
Vallat M; Mathon C; Duprat D; Smolick I; Van Coppenolle F; Salomon JL; Liozon P
Bull Soc Ophtalmol Fr; 1988 Nov; 88(11):1267-8, 1271-2. PubMed ID: 3256434
[No Abstract] [Full Text] [Related]
23. Diabetic retinopathy and microalbuminuria in lean type 2 diabetes mellitus.
Singh SK; Behre A; Singh MK
J Assoc Physicians India; 2001 Apr; 49():439-41. PubMed ID: 11762615
[TBL] [Abstract][Full Text] [Related]
24. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.
Bek T; Erlandsen M
Acta Ophthalmol Scand; 2006 Feb; 84(1):16-20. PubMed ID: 16445434
[TBL] [Abstract][Full Text] [Related]
25. Plasma prekallikrein as a risk factor for diabetic retinopathy.
Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
[TBL] [Abstract][Full Text] [Related]
26. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.
Lee JH; Lee W; Kwon OH; Kim JH; Kwon OW; Kim KH; Lim JB
Ann Clin Lab Sci; 2008; 38(4):361-7. PubMed ID: 18988929
[TBL] [Abstract][Full Text] [Related]
27. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
28. [Comparative study of the role of cytokines in various eye diseases. 2. Diabetic retinopathy].
Slepova OS; Gerasimenko VL; Zakharova GIu; Novikova-Bilak TI
Vestn Oftalmol; 2001; 117(3):35-7. PubMed ID: 11521435
[TBL] [Abstract][Full Text] [Related]
29. [Angiogenic activity and VEGF level in sera of diabetic patients with non-proliferative retinopathy].
Skopiński P; Duda-Król B; Lipińska A; Sommer E; Chorostowska-Wynimko J; Demkow U; Szaflik J; Skopińska-Rózewska E; Struzik E
Klin Oczna; 2004; 106(3 Suppl):421-3. PubMed ID: 15636222
[TBL] [Abstract][Full Text] [Related]
30. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy.
Pan HZ; Zhang H; Chang D; Li H; Sui H
Br J Ophthalmol; 2008 Apr; 92(4):548-51. PubMed ID: 18369071
[TBL] [Abstract][Full Text] [Related]
31. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
[TBL] [Abstract][Full Text] [Related]
32. Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy.
Yorston D; Wickham L; Benson S; Bunce C; Sheard R; Charteris D
Br J Ophthalmol; 2008 Mar; 92(3):365-8. PubMed ID: 18303158
[TBL] [Abstract][Full Text] [Related]
33. [Dyslipoproteinemia and diabetes mellitus].
Vaverková H
Vnitr Lek; 2000 Sep; 46(9):532-8. PubMed ID: 11344647
[TBL] [Abstract][Full Text] [Related]
34. Plasma carotenoids and diabetic retinopathy.
Brazionis L; Rowley K; Itsiopoulos C; O'Dea K
Br J Nutr; 2009 Jan; 101(2):270-7. PubMed ID: 18554424
[TBL] [Abstract][Full Text] [Related]
35. Diabetic retinopathy.
Harding S
Clin Evid; 2002 Jun; (7):580-8. PubMed ID: 12230684
[No Abstract] [Full Text] [Related]
36. Increased protein carbonylation of red blood cell membrane in diabetic retinopathy.
Margetis PI; Antonelou MH; Petropoulos IK; Margaritis LH; Papassideri IS
Exp Mol Pathol; 2009 Aug; 87(1):76-82. PubMed ID: 19379730
[TBL] [Abstract][Full Text] [Related]
37. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of prognosis and cause of disease of vitreous hemorrhage in elderly patients].
Zhang YH; Zhu XH; Tang LS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 30(2):241-2. PubMed ID: 15898446
[No Abstract] [Full Text] [Related]
39. [The morphologic structure of vitreous hemorrhage and posterior vitreous detachment].
Weng N; Wei W; Zhu X
Zhonghua Yan Ke Za Zhi; 2001 Nov; 37(6):425-7. PubMed ID: 11840748
[TBL] [Abstract][Full Text] [Related]
40. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
Shinoda K; Ishida S; Kawashima S; Wakabayashi T; Uchita M; Matsuzaki T; Takayama M; Shinmura K; Yamada M
Curr Eye Res; 2000 Aug; 21(2):655-61. PubMed ID: 11148602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
